FindTrial
Sign In

Time taken for recovery of breathing after stopping muscle relaxant assessed using ventilator parameter

Time taken for recovery of inspiratory effort after Neuromuscular blocking agent (NMBA) administration assessed using P 0.1 and risk factors associated with it : An observational study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/02/080104
Enrollment
100
Registered
2025-02-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B99-B99- Other infectious diseases

Interventions

Intervention1: NIL: NIL

Sponsors

Dr Avinash Kumar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients 18 to 80 years 2.Patients who have received single dose or infusion of NMBA

Exclusion criteria

Exclusion criteria: 1. Patients with advanced directive of limitation of care (non escalation) after shared decision making 2. Patients with bainstem dysfunction . 3. Patient with neuromuscular weakness or toxidromes affecting neuromuscular function 4. Patients intubated in emergency

Design outcomes

Primary

MeasureTime frame
Time taken for recovery of inspiratory efforts after neuromuscular blocking agent (NMBA) administration measured by using using P 0.1 Timepoint: 4 weeks or till ICU discharge—

Secondary

MeasureTime frame
1 Time interval between onset of inspiratory effort on controlled mode to initiation of spontaneous mode 2 Duration of ventilation Timepoint: 4 weeks or till ICU discharge—

Countries

India

Contacts

Public ContactDr Amarja Havaldar

St Johns Medical College and Hospital

havaldar.aa@stjohns.in9036082112

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026